DR10624 Injection

· Zhejiang Doer Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DR10624 Injection, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects [Phase 2]